/

Other

/

Otsuka Pharmaceutical Companies (U.S.)

Otsuka Pharmaceutical Companies (U.S.)

Otsuka Pharmaceutical Companies (U.S.)

Verified Nov 2026

Other

·

United States flag

Princeton, New Jersey

·

Since 2019

Otsuka Pharmaceutical Companies (U.S.) is the American division of the Otsuka Group, headquartered in Princeton, New Jersey, and founded in 2019 as a U.S. entity, with a reported employee band of 1,000 to 5,000. It is publicly listed under the ticker MSET. The company develops and commercializes pharmaceutical products, with a portfolio spanning mental health, oncology, cardio-renal, and neurology. It also serves the medical, automotive, electric-vehicle, and industrial equipment sectors, and holds ISO 9001, ISO 13485, and ISO 14001 certifications. In July 2026, Otsuka ICU Medical LLC announced an expansion of IV solutions manufacturing in North America exceeding $500 million.

Otsuka Pharmaceutical Companies (U.S.)

Verified Nov 2026

AT A GLANCE

Founded

2019

Headquarters

United States flag

Princeton, New Jersey

Employees

1,000-5,000

Ownership

Publicly traded (CSE: MSET)

Otsuka Pharmaceutical Companies (U.S.) at a glance

Revenue

675.1M

Employees

1,000-5,000

Founded

2019

Headquarters

Princeton, New Jersey

Ownership

Publicly traded (CSE: MSET)

Certifications

ISO 13485 · ISO 14001 · ISO 9001

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

STABILITY SIGNALS

Established & strong

FinancialBuffered
QualityCertified
ScaleLarge
TenureUnder 20 years

7 years in operation (founded 2019).

Publicly listed; no distress event on record.

Holds ISO 13485, ISO 14001, ISO 9001 certification(s) per public sources.

Overview

Otsuka Pharmaceutical Companies (U.S.) is the American division of the Otsuka Group, headquartered in Princeton, New Jersey, and founded in 2019 as a U.S. entity, with a reported employee band of 1,000 to 5,000. It is publicly listed under the ticker MSET. The company develops and commercializes pharmaceutical products, with a portfolio spanning mental health, oncology, cardio-renal, and neurology. It also serves the medical, automotive, electric-vehicle, and industrial equipment sectors, and holds ISO 9001, ISO 13485, and ISO 14001 certifications. In July 2026, Otsuka ICU Medical LLC announced an expansion of IV solutions manufacturing in North America exceeding $500 million.

At a glance

Attribute

Detail

Founded

2019

Headquarters

Princeton, New Jersey

Employees

1,000-5,000

Revenue

675.1M

Ownership

Publicly traded (CSE: MSET)

Certifications

ISO 13485 · ISO 14001 · ISO 9001

What Otsuka Pharmaceutical Companies (U.S.) makes

The company holds ISO 9001, ISO 13485, and ISO 14001 certifications and lists Composite among its products, with a facility recorded in Austin, Texas.

Products and capabilities described on the company's own site include Composite (source: otsuka-us.com).

Certifications

Otsuka Pharmaceutical Companies (U.S.) is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Latest developments

Facilities

Otsuka Pharmaceutical Companies (U.S.) is headquartered in Princeton, New Jersey. Public sources also reference these locations:

Company details

The company is publicly listed, reports a revenue band of 675.1M, and is part of the Tokyo-based Otsuka Group, which was established in 1973. Otsuka Pharmaceutical Companies (U.S.) was founded in 2019, has an estimated 1,000-5,000 employees, and is headquartered in Princeton, New Jersey. On the LightSource stability read it is rated "Established & strong": 7 years in operation (founded 2019). Publicly listed; no distress event on record. Holds ISO 13485, ISO 14001, ISO 9001 certification(s) per public sources.

Frequently asked questions

What does Otsuka Pharmaceutical Companies (U.S.) do?

Otsuka Pharmaceutical Companies (U.S.) is the American division of the Otsuka Group, headquartered in Princeton, New Jersey, and founded in 2019 as a U.S. entity, with a reported employee band of 1,000 to 5,000. It is publicly listed under the ticker MSET. The company develops and commercializes pharmaceutical products, with a portfolio spanning mental health, oncology, cardio-renal, and neurology. It also serves the medical, automotive, electric-vehicle, and industrial equipment sectors, and holds ISO 9001, ISO 13485, and ISO 14001 certifications. In July 2026, Otsuka ICU Medical LLC announced an expansion of IV solutions manufacturing in North America exceeding $500 million.

Where is Otsuka Pharmaceutical Companies (U.S.) headquartered?

Otsuka Pharmaceutical Companies (U.S.) is headquartered in Princeton, New Jersey (508 Carnegie Center, Princeton, New Jersey, 08540).

When was Otsuka Pharmaceutical Companies (U.S.) founded?

Otsuka Pharmaceutical Companies (U.S.) was founded in 2019.

How big is Otsuka Pharmaceutical Companies (U.S.)?

Otsuka Pharmaceutical Companies (U.S.) has an estimated 1,000-5,000 employees, with revenue in the 675.1M range.

Is Otsuka Pharmaceutical Companies (U.S.) publicly traded?

Publicly traded (CSE: MSET). Public financial figures are drawn from its filings.

What certifications does Otsuka Pharmaceutical Companies (U.S.) hold?

Otsuka Pharmaceutical Companies (U.S.) lists ISO 13485 · ISO 14001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Princeton, New Jersey (HQ)Headquarters · United States
Princeton, New Jersey (HQ)508 Carnegie Center, Princeton, New Jersey, 08540, United StatesHeadquarters

Phone

+1 609-524-6788

Certification

ISO 13485 · ISO 14001 · ISO 9001

Evaluating suppliers like these?

This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.